The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes
Open accessAbstract
The inability of pancreatic β-cells to make sufficient insulin to control blood sugar is a central feature of the aetiology of most forms of diabetes. In this review we focus on the deleterious effects of oxidative stress and endoplasmic reticulum (ER) stress on β-cell insulin biosynthesis and secretion and on inflammatory signalling and apoptosis with a particular emphasis on type 2 diabetes (T2D). We argue that oxidative stress and ER stress are closely entwined phenomena fundamentally involved in β-cell dysfunction by direct effects on insulin biosynthesis and due to consequences of the ER stress-induced unfolded protein response. We summarise evidence that, although these phenomenon can be driven by intrinsic β-cell defects in rare forms of diabetes, in T2D β-cell stress is driven by a range of local environmental factors including increased drivers of insulin biosynthesis, glucolipotoxicity and inflammatory cytokines. We describe our recent findings that a range of inflammatory cytokines contribute to β-cell stress in diabetes and our discovery that interleukin 22 protects β-cells from oxidative stress regardless of the environmental triggers and can correct much of diabetes pathophysiology in animal models. Finally we summarise evidence that β-cell dysfunction is reversible in T2D and discuss therapeutic opportunities for relieving oxidative and ER stress and restoring glycaemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maedler, K., Schumann, D., Sauter, N. S., Ellingsgaard, H., Bosco, D., Baertschiger, R. M., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 179
RetractedThe Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924
Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., & Mori, K. (2001) · Cell · doi:10.1016/s0092-8674(01)00611-0 · Cited by 4,039
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
Harding, H. P., Zhang, Y., & Ron, D. (1999) · Nature · doi:10.1038/16729 · Cited by 3,310 · cited 1×
“The ultimate goal of the UPR is to restore ER protein biosynthesis, but paradoxically, one initial step is a PERK-mediated phosphorylation of eIF2a, which suppresses translation of secretory proteins to relieve ER load (Harding et al. 1999).”
BackgroundCaspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256
Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., & Ron, D. (2000) · Science · doi:10.1126/science.287.5453.664 · Cited by 2,988
IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA
Calfon, M., Zeng, H., Urano, F., Till, J. H., Hubbard, S. R., Harding, H. P., Clark, S. G., & Ron, D. (2002) · Nature · doi:10.1038/415092a · Cited by 2,820
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Haze, K., Yoshida, H., Yanagi, H., Yura, T., & Mori, K. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.11.3787 · Cited by 2,069
Lee, A.-H., Iwakoshi, N. N., & Glimcher, L. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7448-7459.2003 · Cited by 2,037
Marciniak, S. J., Yun, C. Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., Nagata, K., Harding, H. P., & Ron, D. (2004) · Genes & Development · doi:10.1101/gad.1250704 · Cited by 2,001
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death
Han, J., Back, S. H., Hur, J., Lin, Y.-H., Gildersleeve, R., Shan, J., Yuan, C. L., Krokowski, D., Wang, S., Hatzoglou, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2738 · Cited by 1,691
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538 · cited 1×
“Examples include circulating fatty acids as ligands for GPR40 (Itoh et al. 2003) and GPR119 (Soga et al. 2005).”
BackgroundInsulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
ER Stress Triggers Apoptosis by Activating BH3-Only Protein Bim
Puthalakath, H., O'Reilly, L. A., Gunn, P., Lee, L., Kelly, P. N., Huntington, N. D., Hughes, P. D., Michalak, E. M., McKimm-Breschkin, J., Motoyama, N., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.027 · Cited by 1,425
Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease
Cao, S. S., & Kaufman, R. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5851 · Cited by 1,363
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330 · cited 1×
“…proteins in the extracellular space, and accumulation of b-amyloid in human pancreatic islets is a well-characterised feature of T2D that has been linked with oxidative stress, inflammatory signalling and apoptosis (Zraika et al. 2009, Masters et al. 2010, Jurgens et al. 2011, Meier et al. 2014).”
BackgroundMolecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164 · cited 1×
“…half the pancreas has a modest effect on glycaemic control (Menge et al. 2009); and bariatric surgery (Saliba et al. 2009), intense calorie restriction (Lim et al. 2011, Jackness et al. 2013) and administration of GLP1R agonists (Samson & Garber 2013) restore glycaemic control and b-cell function.”
BackgroundRegulated Ire1-dependent decay of messenger RNAs in mammalian cells
Hollien, J., Lin, J. H., Li, H., Stevens, N., Walter, P., & Weissman, J. S. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200903014 · Cited by 1,030
Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922
Diabetes Mellitus and the β Cell: The Last Ten Years
Ashcroft, F. M., & Rorsman, P. (2012) · Cell · doi:10.1016/j.cell.2012.02.010 · Cited by 902 · cited 1×
“…dysfunction are an intrinsically linked phenomenon, several lines of evidence, including genetic linkages from genome-wide association studies, have firmly focussed attention on the b-cell as the critical primary contributor to hyperglycaemia in T2D (Ashcroft & Rorsman 2012, Rosengren et al. 2012).”
Lerner, A. G., Upton, J.-P., Praveen, P. V. K., Ghosh, R., Nakagawa, Y., Igbaria, A., Shen, S., Nguyen, V., Backes, B. J., Heiman, M., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.007 · Cited by 846
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
Pancreatic β‐cell mass in European subjects with type 2 diabetes
Rahier, J., Guiot, Y., Goebbels, R. M., Sempoux, C., & Henquin, J. C. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00969.x · Cited by 756 · cited 1×
“…multiple pathways from oxidative and ER stress to apoptosis, there are somewhat divergent data about the extent of b-cell depletion in the human disease (Butler et al. 2003, Rahier et al. 2008), and we argue that dysfunctional insulin biosynthesis is the primary underlying feature of the disease.”
BackgroundInsulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production
Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695
Song, B., Scheuner, D., Ron, D., Pennathur, S., & Kaufman, R. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34587 · Cited by 693
Endoplasmic reticulum stress, obesity and diabetes
Cnop, M., Foufelle, F., & Velloso, L. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.010 · Cited by 682
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Doyle, M. E., & Egan, J. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.007 · Cited by 680
Oslowski, C. M., Hara, T., O'Sullivan-Murphy, B., Kanekura, K., Lu, S., Hara, M., Ishigaki, S., Zhu, L. J., Hayashi, E., Hui, S. T., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.005 · Cited by 675
Coppieters, K. T., Dotta, F., Amirian, N., Campbell, P. D., Kay, T. W. H., Atkinson, M. A., Roep, B. O., & von Herrath, M. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111187 · Cited by 672
Deng, J., Lu, P. D., Zhang, Y., Scheuner, D., Kaufman, R. J., Sonenberg, N., Harding, H. P., & Ron, D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10161-10168.2004 · Cited by 643
Endoplasmic Reticulum Stress and Type 2 Diabetes
Back, S. H., & Kaufman, R. J. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072909-095555 · Cited by 619
Zhang, P., McGrath, B., Li, S., Frank, A., Zambito, F., Reinert, J., Gannon, M., Ma, K., McNaughton, K., & Cavener, D. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3864-3874.2002 · Cited by 604
Initiation and execution of lipotoxic ER stress in pancreatic β-cells
Cunha, D. A., Hekerman, P., Ladrière, L., Bazarra-Castro, A., Ortis, F., Wakeham, M. C., Moore, F., Rasschaert, J., Cardozo, A. K., Bellomo, E., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.026062 · Cited by 594
Cross, B. C. S., Bond, P. J., Sadowski, P. G., Jha, B. K., Zak, J., Goodman, J. M., Silverman, R. H., Neubert, T. A., Baxendale, I. R., Ron, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115623109 · Cited by 591
Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death
Borradaile, N. M., Han, X., Harp, J. D., Gale, S. E., Ory, D. S., & Schaffer, J. E. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600299-jlr200 · Cited by 564
Therapeutic opportunities of the IL-22–IL-22R1 system
Sabat, R., Ouyang, W., & Wolk, K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4176 · Cited by 562
Yoshioka, M., Kayo, T., Ikeda, T., & Koizuni, A. (1997) · Diabetes · doi:10.2337/diab.46.5.887 · Cited by 534
Oxidative stress: the vulnerable β-cell
Lenzen, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360343 · Cited by 531
The Unfolded Protein Response: A Pathway That Links Insulin Demand with β-Cell Failure and Diabetes
Scheuner, D., & Kaufman, R. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0039 · Cited by 531
Cardozo, A. K., Ortis, F., Storling, J., Feng, Y.-M., Rasschaert, J., Tonnesen, M., Van Eylen, F., Mandrup-Poulsen, T., Herchuelz, A., & Eizirik, D. L. (2005) · Diabetes · doi:10.2337/diabetes.54.2.452 · Cited by 523
The SLC2 family of facilitated hexose and polyol transporters
Uldry, M., & Thorens, B. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1085-0 · Cited by 501
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
Wang, X., Ota, N., Manzanillo, P., Kates, L., Zavala-Solorio, J., Eidenschenk, C., Zhang, J., Lesch, J., Lee, W. P., Ross, J., et al. (2014) · Nature · doi:10.1038/nature13564 · Cited by 500
Yusta, B., Baggio, L. L., Estall, J. L., Koehler, J. A., Holland, D. P., Li, H., Pipeleers, D., Ling, Z., & Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.001 · Cited by 446
IL‐22, not simply a Th17 cytokine
Rutz, S., Eidenschenk, C., & Ouyang, W. (2013) · Immunological Reviews · doi:10.1111/imr.12027 · Cited by 435
Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit
Das, I., Krzyzosiak, A., Schneider, K., Wrabetz, L., D’Antonio, M., Barry, N., Sigurdardottir, A., & Bertolotti, A. (2015) · Science · doi:10.1126/science.aaa4484 · Cited by 433
Lipson, K. L., Fonseca, S. G., Ishigaki, S., Nguyen, L. X., Foss, E., Bortell, R., Rossini, A. A., & Urano, F. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.007 · Cited by 430
Jiang, H.-Y., Wek, S. A., McGrath, B. C., Scheuner, D., Kaufman, R. J., Cavener, D. R., & Wek, R. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5651-5663.2003 · Cited by 423
Powell, D. W. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.001af.x · Cited by 422
The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
Marchetti, P., Bugliani, M., Lupi, R., Marselli, L., Masini, M., Boggi, U., Filipponi, F., Weir, G. C., Eizirik, D. L., & Cnop, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0816-8 · Cited by 413 · cited 1×
“…stress are well-accepted phenomena in a range of different animal models of T1D and T2D, unfortunately, the direct evidence from human disease is relatively scant and therefore less compelling (Marchetti et al. 2007, Donath et al. 2009, Cnop et al. 2012, Marhfour et al. 2012, Tersey et al. 2012).”
BackgroundKars, M., Yang, L., Gregor, M. F., Mohammed, B. S., Pietka, T. A., Finck, B. N., Patterson, B. W., Horton, J. D., Mittendorfer, B., Hotamisligil, G. S., et al. (2010) · Diabetes · doi:10.2337/db10-0308 · Cited by 400
Wang, Z., & Thurmond, D. C. (2009) · Journal of Cell Science · doi:10.1242/jcs.034355 · Cited by 386 · cited 1×
“The first phase is fast and of short duration, due to the release of the readily releasable pool of insulin vesicles, and the second phase is more sustained and of longer duration, resulting from the reserve pool of insulin vesicles (Wang & Thurmond 2009, Seino et al. 2011).”
BackgroundKeane, K. N., Cruzat, V. F., Carlessi, R., de Bittencourt, P. I. H., & Newsholme, P. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/181643 · Cited by 383
Soga, T., Ohishi, T., Matsui, T., Saito, T., Matsumoto, M., Takasaki, J., Matsumoto, S.-I., Kamohara, M., Hiyama, H., Yoshida, S., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.120 · Cited by 367
Back, S. H., Scheuner, D., Han, J., Song, B., Ribick, M., Wang, J., Gildersleeve, R. D., Pennathur, S., & Kaufman, R. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.06.002 · Cited by 366
Molecular Physiology of Mammalian Glucokinase
Iynedjian, P. B. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8322-9 · Cited by 365
Dynamics of insulin secretion and the clinical implications for obesity and diabetes
Seino, S., Shibasaki, T., & Minami, K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45680 · Cited by 364
Tersey, S. A., Nishiki, Y., Templin, A. T., Cabrera, S. M., Stull, N. D., Colvin, S. C., Evans-Molina, C., Rickus, J. L., Maier, B., & Mirmira, R. G. (2012) · Diabetes · doi:10.2337/db11-1293 · Cited by 353 · cited 2×
“…model of autoimmune diabetes where ER stress has been shown to develop early in pathology prior to frank insulitis or the onset of diabetes (Tersey et al. 2012), CHOP deficiency did not affect the development of insulitis, diabetes or apoptosis but did delay the appearance of insulin…”
BackgroundThioredoxin-Interacting Protein
Chen, J., Saxena, G., Mungrue, I. N., Lusis, A. J., & Shalev, A. (2008) · Diabetes · doi:10.2337/db07-0715 · Cited by 350
Pancreatic β-cell identity, glucose sensing and the control of insulin secretion
Rutter, G. A., Pullen, T. J., Hodson, D. J., & Martinez-Sanchez, A. (2015) · Biochemical Journal · doi:10.1042/bj20141384 · Cited by 339
Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
Donath, M. Y., Dalmas, É., Sauter, N. S., & Böni-Schnetzler, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.001 · Cited by 338 · cited 2×
“…impaired secretory pathway function, b-cell apoptosis and local islet inflammation can progressively http://jme.endocrinology-journals.org 2016 Society for Endocrinology DOI: 10.1530/JME-15-0232 Printed in Great Britain develop in T2D (Donath et al. 2013, Eizirik et al. 2013, Montane et al. 2014).”
BackgroundInfluentialIslet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., & Ehses, J. A. (2009) · Physiology · doi:10.1152/physiol.00032.2009 · Cited by 330
β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition
Jurgens, C. A., Toukatly, M. N., Fligner, C. L., Udayasankar, J., Subramanian, S. L., Zraika, S., Aston-Mourney, K., Carr, D. B., Westermark, P., Westermark, G. T., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.02.036 · Cited by 329
ER stress activates the NLRP3 inflammasome via an UPR-independent pathway
Menu, P., Mayor, A., Zhou, R., Tardivel, A., Ichijo, H., Mori, K., & Tschopp, J. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.132 · Cited by 322
The pancreas anatomy conditions the origin and properties of resident macrophages
Calderon, B., Carrero, J. A., Ferris, S. T., Sojka, D. K., Moore, L., Epelman, S., Murphy, K. M., Yokoyama, W. M., Randolph, G. J., & Unanue, E. R. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150496 · Cited by 321
Engin, F., Yermalovich, A., Nguyen, T., Hummasti, S., Fu, W., Eizirik, D. L., Mathis, D., & Hotamisligil, G. S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006534 · Cited by 318
Kimata, Y., Ishiwata-Kimata, Y., Ito, T., Hirata, A., Suzuki, T., Oikawa, D., Takeuchi, M., & Kohno, K. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704166 · Cited by 300
ATF6α induces XBP1-independent expansion of the endoplasmic reticulum
Bommiasamy, H., Back, S. H., Fagone, P., Lee, K., Meshinchi, S., Vink, E., Sriburi, R., Frank, M., Jackowski, S., Kaufman, R. J., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.045625 · Cited by 298
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., & Donath, M. Y. (2012) · Diabetes Care · doi:10.2337/dc11-2219 · Cited by 294
Yamazaki, H., Hiramatsu, N., Hayakawa, K., Tagawa, Y., Okamura, M., Ogata, R., Huang, T., Nakajima, S., Yao, J., Paton, A. W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900017 · Cited by 291
Zhang, W., Feng, D., Li, Y., Iida, K., McGrath, B., & Cavener, D. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.002 · Cited by 285
Bensellam, M., Laybutt, D. R., & Jonas, J.-C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.003 · Cited by 284
The interplay between endoplasmic reticulum stress and inflammation
Hasnain, S. Z., Lourie, R., Das, I., Chen, A. C., & McGuckin, M. A. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.112 · Cited by 282
Self-citationShkoda, A., Ruiz, P. A., Daniel, H., Kim, S. C., Rogler, G., Sartor, R. B., & Haller, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.030 · Cited by 277
Lee, A.-H., Heidtman, K., Hotamisligil, G. S., & Glimcher, L. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105564108 · Cited by 277
Kaneko, M., Niinuma, Y., & Nomura, Y. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.931 · Cited by 275
Promlek, T., Ishiwata-Kimata, Y., Shido, M., Sakuramoto, M., Kohno, K., & Kimata, Y. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-04-0295 · Cited by 269
Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes
Marhfour, I., Lopez, X. M., Lefkaditis, D., Salmon, I., Allagnat, F., Richardson, S. J., Morgan, N. G., & Eizirik, D. L. (2012) · Diabetologia · doi:10.1007/s00125-012-2604-3 · Cited by 267
Jackness, C., Karmally, W., Febres, G., Conwell, I. M., Ahmed, L., Bessler, M., McMahon, D. J., & Korner, J. (2013) · Diabetes · doi:10.2337/db12-1762 · Cited by 267
Hasnain, S. Z., Borg, D. J., Harcourt, B. E., Tong, H., Sheng, Y. H., Ng, C. P., Das, I., Wang, R., Chen, A. C.-H., Loudovaris, T., et al. (2014) · Nature Medicine · doi:10.1038/nm.3705 · Cited by 263
Self-citationSriburi, R., Bommiasamy, H., Buldak, G. L., Robbins, G. R., Frank, M., Jackowski, S., & Brewer, J. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609490200 · Cited by 262
Metabolic cycling in control of glucose-stimulated insulin secretion
Jensen, M. V., Joseph, J. W., Ronnebaum, S. M., Burgess, S. C., Sherry, A. D., & Newgard, C. B. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90604.2008 · Cited by 260
Engin, F., & Hotamisligil, G. S. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01282.x · Cited by 245
Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes
Rosengren, A. H., Braun, M., Mahdi, T., Andersson, S. A., Travers, M. E., Shigeto, M., Zhang, E., Almgren, P., Ladenvall, C., Axelsson, A. S., et al. (2012) · Diabetes · doi:10.2337/db11-1516 · Cited by 237 · cited 1×
“…dysfunction are an intrinsically linked phenomenon, several lines of evidence, including genetic linkages from genome-wide association studies, have firmly focussed attention on the b-cell as the critical primary contributor to hyperglycaemia in T2D (Ashcroft & Rorsman 2012, Rosengren et al. 2012).”
BackgroundIL-1 produced and released endogenously within human islets inhibits beta cell function.
Arnush, M., Heitmeier, M. R., Scarim, A. L., Marino, M. H., Manning, P. T., & Corbett, J. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci844 · Cited by 237
The Keap1-Nrf2 system and diabetes mellitus
Uruno, A., Yagishita, Y., & Yamamoto, M. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.12.012 · Cited by 231 · cited 1×
“IL22 alters these genes independently of oxidative stress and can therefore protect cells from subsequent stressors, distinguishing IL22 from the Nrf2 transcription factor that is induced by oxidative stress (Uruno et al. 2015).”
BackgroundMitochondrial dysfunction in pancreatic β cells
Supale, S., Li, N., Brun, T., & Maechler, P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.002 · Cited by 231
Igoillo-Esteve, M., Marselli, L., Cunha, D. A., Ladrière, L., Ortis, F., Grieco, F. A., Dotta, F., Weir, G. C., Marchetti, P., Eizirik, D. L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1707-y · Cited by 227
Carpentier, A., Mittelman, S. D., Bergman, R. N., Giacca, A., & Lewis, G. F. (2000) · Diabetes · doi:10.2337/diabetes.49.3.399 · Cited by 226
Chen, J., Hui, S. T., Couto, F. M., Mungrue, I. N., Davis, D. B., Attie, A. D., Lusis, A. J., Davis, R. A., & Shalev, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-111690 · Cited by 225
Activation of NF‐κB by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers
Pahl, H. L., & Baeuerle, P. A. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00800-9 · Cited by 224
Endo, M., Mori, M., Akira, S., & Gotoh, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6245 · Cited by 220
Zraika, S., Hull, R. L., Udayasankar, J., Aston-Mourney, K., Subramanian, S. L., Kisilevsky, R., Szarek, W. A., & Kahn, S. E. (2009) · Diabetologia · doi:10.1007/s00125-008-1255-x · Cited by 214
Eizirik, D. L., Miani, M., & Cardozo, A. K. (2013) · Diabetologia · doi:10.1007/s00125-012-2762-3 · Cited by 212
Julier, C., & Nicolino, M. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-29 · Cited by 209
Glucose regulation of insulin gene expression in pancreatic β-cells
Andrali, S. S., Sampley, M. L., Vanderford, N. L., & Özcan, S. (2008) · Biochemical Journal · doi:10.1042/bj20081029 · Cited by 201
Mahdi, T., Hänzelmann, S., Salehi, A., Muhammed, S. J., Reinbothe, T. M., Tang, Y., Axelsson, A. S., Zhou, Y., Jing, X., Almgren, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.009 · Cited by 193
Minireview: Thioredoxin-Interacting Protein: Regulation and Function in the Pancreatic β-Cell
Shalev, A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1095 · Cited by 185
Quan, W., Hur, K. Y., Lim, Y., Oh, S. H., Lee, J.-C., Kim, K. H., Kim, G. H., Kim, S.-W., Kim, H. L., Lee, M.-K., et al. (2012) · Diabetologia · doi:10.1007/s00125-011-2350-y · Cited by 184
Sloan-Lancaster, J., Abu-Raddad, E., Polzer, J., Miller, J. W., Scherer, J. C., De Gaetano, A., Berg, J. K., & Landschulz, W. H. (2013) · Diabetes Care · doi:10.2337/dc12-1835 · Cited by 184
Busch, A. K., Gurisik, E., Cordery, D. V., Sudlow, M., Denyer, G. S., Laybutt, D. R., Hughes, W. E., & Biden, T. J. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2917 · Cited by 183
Endoplasmic Reticulum Stress, Pancreatic -Cell Degeneration, and Diabetes
Papa, F. R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007666 · Cited by 182
Sun, J., Cui, J., He, Q., Chen, Z., Arvan, P., & Liu, M. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.01.001 · Cited by 179
β-Cell Dysfunction Due to Increased ER Stress in a Stem Cell Model of Wolfram Syndrome
Shang, L., Hua, H., Foo, K., Martinez, H., Watanabe, K., Zimmer, M., Kahler, D. J., Freeby, M., Chung, W., LeDuc, C., et al. (2014) · Diabetes · doi:10.2337/db13-0717 · Cited by 176
Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?
Walker, J. N., Ramracheya, R., Zhang, Q., Johnson, P. R. V., Braun, M., & Rorsman, P. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01450.x · Cited by 176
Newsholme, P., Rebelato, E., Abdulkader, F., Krause, M. D. S., Carpinelli, Â. R., & Curi, R. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0072 · Cited by 175
Elouil, H., Bensellam, M., Guiot, Y., Mierde, D. V., Pascal, S. M. A., Schuit, F. C., & Jonas, J. (2007) · Diabetologia · doi:10.1007/s00125-007-0674-4 · Cited by 171
Thuerauf, D. J., Marcinko, M. C., Belmont, P. J., & Glembotski, C. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701213200 · Cited by 169
Calcium Efflux From the Endoplasmic Reticulum Leads to β-Cell Death
Hara, T., Mahadevan, J., Kanekura, K., Hara, M., Lu, S., & Urano, F. (2014) · Endocrinology · doi:10.1210/en.2013-1519 · Cited by 166
Boslem, E., MacIntosh, G. L., Preston, A. M., Bartley, C., Busch, A. K., Fuller, M., Laybutt, D. R., Meikle, P. J., & Biden, T. J. (2011) · Biochemical Journal · doi:10.1042/bj20101867 · Cited by 166
Gurzov, E. N., Ortis, F., Cunha, D. A., Gosset, G., Li, M., Cardozo, A. K., & Eizirik, D. L. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.99 · Cited by 160
Usui, M., Yamaguchi, S., Tanji, Y., Tominaga, R., Ishigaki, Y., Fukumoto, M., Katagiri, H., Mori, K., Oka, Y., & Ishihara, H. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.004 · Cited by 160
Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes
Novials, A., Montane, J., & Cadavez-Trigo, L. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s37649 · Cited by 159
Rissanen, A., Howard, C. P., Botha, J., Thuren, T. Y., & for the Global Investigators (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01637.x · Cited by 153
Allagnat, F., Christulia, F., Ortis, F., Pirot, P., Lortz, S., Lenzen, S., Eizirik, D. L., & Cardozo, A. K. (2010) · Diabetologia · doi:10.1007/s00125-010-1699-7 · Cited by 151
PERK (EIF2AK3) Regulates Proinsulin Trafficking and Quality Control in the Secretory Pathway
Gupta, S., McGrath, B. C., & Cavener, D. R. (2010) · Diabetes · doi:10.2337/db09-1064 · Cited by 151
Causes and cures for endoplasmic reticulum stress in lipotoxic β ‐cell dysfunction
Cnop, M., Ladrière, L., Igoillo‐Esteve, M., Moura, R. F., & Cunha, D. A. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01279.x · Cited by 150
Flowers, J. B., Rabaglia, M. E., Schueler, K. L., Flowers, M. T., Hong, L., Keller, M. P., Ntambi, J. M., & Attie, A. (2007) · Diabetes · doi:10.2337/db06-1142 · Cited by 150
Hiramatsu, N., Messah, C., Han, J., LaVail, M. M., Kaufman, R. J., & Lin, J. H. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-11-0664 · Cited by 149
Cytokine-Induced β-Cell Death Is Independent of Endoplasmic Reticulum Stress Signaling
Åkerfeldt, M. C., Howes, J. E., Chan, J. Y., Stevens, V. A., Boubenna, N., McGuire, H. M., King, C., Biden, T. J., & Laybutt, D. R. (2008) · Diabetes · doi:10.2337/db07-1802 · Cited by 146
Physiological roles of regulated Ire1 dependent decay
Coelho, D. S., & Domingos, P. M. D. N. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00076 · Cited by 141
INS-gene mutations: From genetics and beta cell biology to clinical disease
Liu, M. R., Sun, J., Cui, J., Chen, W., Guo, H., Barbetti, F., & Arvan, P. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.001 · Cited by 133
Miki, T., Minami, K., Shinozaki, H., Matsumura, K., Saraya, A., Ikeda, H., Yamada, Y., Holst, J. J., & Seino, S. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1056 · Cited by 133
Luo, Z.-F., Feng, B., Mu, J., Qi, W., Zeng, W., Guo, Y., Pang, Q., Ye, Z.-L., Liu, L., & Fa-huan, Y. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.04.005 · Cited by 129
Li, N., Ли, Б., Brun, T., Deffert-Delbouille, C., Mahiout, Z., Daali, Y., Ma, X., Krause, K., & Maechler, P. (2012) · Diabetes · doi:10.2337/db12-0009 · Cited by 129
Chen, J., Fontès, G., Saxena, G., Poitout, V., & Shalev, A. (2009) · Diabetes · doi:10.2337/db09-0949 · Cited by 127
Green, C. D., & Olson, L. K. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00544.2010 · Cited by 125
Islet inflammation: a unifying target for diabetes treatment?
Imai, Y., Dobrian, A. D., Morris, M. A., & Nadler, J. L. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.01.007 · Cited by 122
Divergent Roles of IRE1α and PERK in the Unfolded Protein Response
Schroder, M., & Kaufman, R. J. (2006) · Current Molecular Medicine · doi:10.2174/156652406775574569 · Cited by 121
Xue, J., Nguyen, D. T., & Habtezion, A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.051 · Cited by 120
Pancreatic α Cells are Resistant to Metabolic Stress-induced Apoptosis in Type 2 Diabetes
Marroquí, L., Masini, M., Merino, B., Grieco, F. A., Millard, I., Dubois, C., Quesada, I., Marchetti, P., Cnop, M., & Eizirik, D. L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.03.012 · Cited by 118
Harding, H. P., Zyryanova, A. F., & Ron, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.428987 · Cited by 114
Chen, H., Li, X., & Epstein, P. N. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1437 · Cited by 111
Regulated IRE1‐dependent decay participates in curtailing immunoglobulin secretion from plasma cells
Benhamron, S., Hadar, R., Iwawaki, T., So, J., Lee, A., & Tirosh, B. (2013) · European Journal of Immunology · doi:10.1002/eji.201343953 · Cited by 109
Feng, D., Park, O., Radaeva, S., Wang, H., Yin, S., Kong, X., Zheng, M., Zakhari, S., Kolls, J. K., & Gao, B. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.3967 · Cited by 109
Hayden, M. R., Patel, K., Habibi, J., Gupta, D., Tekwani, S. S., Whaley‐Connell, A. T., & Sowers, J. R. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00024.x · Cited by 108
Tsunekawa, S., Yamamoto, N., Tsukamoto, K., Itoh, Y., Kaneko, Y. K., Kimura, T., Ariyoshi, Y., Miura, Y., Oiso, Y., & Niki, I. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0148 · Cited by 107
Protein tyrosine phosphatases: molecular switches in metabolism and diabetes
Gurzov, E. N., Stanley, W. J., Brodnicki, T. C., & Thomas, H. E. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.10.004 · Cited by 105
The β-Cell/EC Axis: How Do Islet Cells Talk to Each Other?
Peiris, H., Bonder, C., Coates, P., Keating, D., & Jessup, C. (2013) · Diabetes · doi:10.2337/db13-0617 · Cited by 98
Anvari, E., Wikström, P., Walum, E., & Welsh, N. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1067697 · Cited by 97
Metabolic consequences of a 50% partial pancreatectomy in humans
Menge, B., Schrader, H., Breuer, T. G. K., Dabrowski, Y., Uhl, W. H., Schmidt, W. E., & Meier, J. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1219-1 · Cited by 96
Role of islet β cell autophagy in the pathogenesis of diabetes
Lee, M. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.08.005 · Cited by 88
Targeting inflammation in the treatment of type 2 diabetes
Donath, M. Y. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12172 · Cited by 83 · cited 2×
“IL1b antagonists have been trialled in T2D with some efficacy, but overall with mixed results, suggesting that more appropriate patient stratification may be required (Cavelti-Weder et al. 2011, 2012, Rissanen et al. 2012, Boni-Schnetzler & Donath 2013, Donath 2013, Sloan-Lancaster et al. 2013).”
BackgroundX-Box Binding Protein 1 Is Essential for Insulin Regulation of Pancreatic α-Cell Function
Akiyama, M., Liew, C. W., Lu, S., Hu, J. Y., Martinez, R., Hambro, B., Kennedy, R. T., & Kulkarni, R. (2013) · Diabetes · doi:10.2337/db12-1747 · Cited by 83
Meier, D. T., Morcos, M., Samarasekera, T., Zraika, S., Hull, R. L., & Kahn, S. E. (2014) · Diabetologia · doi:10.1007/s00125-014-3304-y · Cited by 82
Cadavez, L., Montané, J., Alcarraz‐Vizán, G., Visa, M., Laia, V.-F., Servitja, J., & Novials, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101797 · Cited by 78
Protective and Pathological Properties of IL-22 in Liver Disease
Cobleigh, M. A., & Robek, M. D. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.043 · Cited by 77
Unraveling the Science of Incretin Biology
Nauck, M. A. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2009.05.012 · Cited by 72
Merry, T. L., Tran, M., Stathopoulos, M., Wiede, F., Fam, B. C., Dodd, G. T., Clarke, I. J., Watt, M. J., Andrikopoulos, S., & Tiganis, T. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5428 · Cited by 72
Gurgul-Convey, E., Mehmeti, I., Lortz, S., & Lenzen, S. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0747-1 · Cited by 70
Targeted disruption of the Chop gene delays endoplasmic reticulum stress–mediated diabetes
Oyadomari, S., Koizumi, A., Takeda, K., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214550 · Cited by 70
Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes
Cavelti‐Weder, C., Furrer, R., Keller, C., Babians-Brunner, A., Solinger, A. M., Gast, H., Fontana, A., Donath, M. Y., & Penner, I. (2011) · Diabetes Care · doi:10.2337/dc11-1196 · Cited by 69
Chan, J. Y., Cooney, G. J., Biden, T. J., & Laybutt, D. R. (2011) · Diabetologia · doi:10.1007/s00125-011-2139-z · Cited by 69
Arcidiacono, B., Iiritano, S., Chiefari, E., Brunetti, F. S., Gu, G., Foti, D. P., & Brunetti, A. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00237 · Cited by 68 · cited 1×
“Several transcription factors that regulate insulin transcription are glucose sensitive, including PDX1, MAFA and HMGA1, and this is enhanced by cAMP and PKA activation (Andrali et al. 2008, Arcidiacono et al. 2014, Rutter et al. 2015).”
BackgroundHull, R. L., Zraika, S., Udayasankar, J., Aston‐Mourney, K., Subramanian, S. L., & Kahn, S. E. (2009) · Diabetologia · doi:10.1007/s00125-009-1329-4 · Cited by 68
Teodoro, T., Odisho, T., Sidorova‐Darmos, E., & Volchuk, A. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00160.2011 · Cited by 67
Role of Pancreatic Transcription Factors in Maintenance of Mature β-Cell Function
Kaneto, H., & Matsuoka, T. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16036281 · Cited by 67
Wicksteed, B. L., Uchizono, Y., Alarcón, C., McCuaig, J. F., Shalev, A., & Rhodes, C. J. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.02.007 · Cited by 61
Zatyka, M., Xavier, G. D. S., Bellomo, E. A., Leadbeater, W. E., Astuti, D., Smith, J. C., Michelangeli, F., Rutter, G. A., & Barrett, T. G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu499 · Cited by 59
GLP-1R agonist therapy for diabetes: benefits and potential risks
Samson, S. L., & Garber, A. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32835edb32 · Cited by 55
The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes
Hill, T., Krougly, O., Nikoopour, E., Bellemore, S. M., Lee‐Chan, E., Fouser, L. A., Hill, D. J., & Singh, B. (2013) · Cell Regeneration · doi:10.1186/2045-9769-2-2 · Cited by 55
Miani, M., Barthson, J., Colli, M. L., Brozzi, F., Cnop, M., & Eizirik, D. L. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.236 · Cited by 54
Kumar, P., Rajasekaran, K., Palmer, J. M., Thakar, M. S., & Malarkannan, S. (2013) · Journal of Cancer · doi:10.7150/jca.5048 · Cited by 52
Kacheva, S., Lenzen, S., & Gurgul-Convey, E. (2011) · Cytokine · doi:10.1016/j.cyto.2011.04.002 · Cited by 49
β-Cell Responses to Nitric Oxide
Broniowska, K. A., Oleson, B. J., & Corbett, J. A. (2014) · Vitamins & Hormones · doi:10.1016/b978-0-12-800174-5.00012-0 · Cited by 48 · cited 1×
“…attributable to the induction of oxidative stress via a variety of downstream pathways, the most notable being the induction of NOS2 and production of NO (Arnush et al. 1998, Chan et al. 2011, Ellingsgaard et al. 2011, Gurgul-Convey et al. 2011, Kacheva et al. 2011, Broniowska et al. 2013, 2014).”
BackgroundModulation of Apoptosis Pathways by Oxidative Stress and Autophagy in β Cells
Wang, M., Crager, M., & Pugazhenthi, S. (2012) · Experimental Diabetes Research · doi:10.1155/2012/647914 · Cited by 48
How biologics targeting the IL‐1 system are being considered for the treatment of type 2 diabetes
Böni‐Schnetzler, M., & Donath, M. Y. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04297.x · Cited by 48
Interleukin 22 Receptor 1 Expression in Pancreas Islets
Shioya, M., Andoh, A., Kakinoki, S., Nishida, A., & Fujiyama, Y. (2008) · Pancreas · doi:10.1097/mpa.0b013e3181594258 · Cited by 47
Lipid-induced ER stress in yeast and β cells: parallel trails to a common fate
Pineau, L., & Ferreira, T. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00674.x · Cited by 46
Redox Homeostasis in Pancreatic Cells
Ježek, P., Dlasková, A., & Plecitá‐Hlavatá, L. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/932838 · Cited by 45
Endocrine and metabolic response to gastric bypass
Saliba, J., Wattacheril, J. J., & Abumrad, N. N. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832e1b14 · Cited by 43
Reduced levels of SCD1 accentuate palmitate-induced stress in insulin-producing β-cells
Thörn, K., Hovsepyan, M., & Bergsten, P. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-108 · Cited by 43
Contreras, J. L., Smyth, C. A., Bilbao, G., Eckstein, C. P., Young, C. J., Thompson, J. A., Curiel, D. T., & Eckhoff, D. E. (2003) · Transplant International · doi:10.1007/s00147-003-0619-x · Cited by 41
Yang, C., diIorio, P. J., Jurczyk, A., O’Sullivan-Murphy, B., Urano, F., & Bortell, R. (2013) · Diabetologia · doi:10.1007/s00125-013-3044-4 · Cited by 40
Chen, J. J.-W., Genereux, J. C., & Wiseman, R. L. (2015) · IUBMB Life · doi:10.1002/iub.1386 · Cited by 32
The Apoptosis Inhibitor ARC Alleviates the ER Stress Response to Promote β-Cell Survival
McKimpson, W. M., Weinberger, J. F., Czerski, L., Zheng, M., Crow, M. T., Pessin, J. E., Chua, S. C., & Kitsis, R. N. (2012) · Diabetes · doi:10.2337/db12-0504 · Cited by 32
Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
Kim, J., Lim, D.-M., Park, H.-S., Moon, C., Choi, K.-J., Lee, S., Baik, H., Park, K., & Kim, B.-J. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11072fp · Cited by 30
Chan, J. Y., Biden, T. J., & Laybutt, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2657-3 · Cited by 28
Do β-Cells Generate Peroxynitrite in Response to Cytokine Treatment?
Broniowska, K. A., Mathews, C. E., & Corbett, J. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.522243 · Cited by 25
Satoh, T., Abiru, N., Kobayashi, M., Zhou, H., Nakamura, K., Kuriya, G., Nakamura, H., Nagayama, Y., Kawasaki, E., Yamasaki, H., et al. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0576-2 · Cited by 25
4‐Phenyl butyric acid does not generally reduce glucose levels in rodent models of diabetes
Xu, T., Chen, R., Wang, P., Zhang, R., Ke, S., & Miao, C. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05328.x · Cited by 19
Haupt, A., Guthoff, M., Schäfer, S., Kirchhoff, K., Machicao, F. E., Gallwitz, B., Staiger, H., Stefan, N., Fritsche, A., & Häring, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1876 · Cited by 18
Collardeau‐Frachon, S., Vasiljevic, A., Jouvet, A., Bouvier, R., Senée, V., & Nicolino, M. P. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12201 · Cited by 16
Incretin hormones and beta-cell mass expansion: what we know and what is missing?
Tortosa, F., & Dotta, F. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.795175 · Cited by 10
Cited by
Adipose tissue and insulin resistance in obese
Ahmed, B., Sultana, R., & Greene, M. W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111315 · Cited by 1,047
Lipid droplet functions beyond energy storage
Welte, M. A., & Gould, A. P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.006 · Cited by 577
The Role of Oxidative Stress in Pancreatic β Cell Dysfunction in Diabetes
Eguchi, N., Vaziri, N. D., Dafoe, D. C., & Ichii, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041509 · Cited by 341
Rieusset, J. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0416-1 · Cited by 248
Xin, Y., Dominguez Gutierrez, G., Okamoto, H., Kim, J., Lee, A.-H., Adler, C., Ni, M., Yancopoulos, G. D., Murphy, A. J., & Gromada, J. (2018) · Diabetes · doi:10.2337/db18-0365 · Cited by 191
Metadata
- Authors
- Hasnain, S. Z., Prins, J. B., & McGuckin, M. A.
- Venue
- Journal of Molecular Endocrinology
- Publisher
- Bioscientifica
- Published
- 2015-11-17
- Volume
- 56
- Issue
- 2
- Pages
- R33-R54
- ISSN
- 0952-5041 (ISSN-L)
- 1479-6813
- OpenAlex
- W2264618409
- Cited by
- 253
- References
- 188
- FWCI
- 19.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.